Welch, Jessica
University of Oxford · Oxford University Hospitals NHS Trust
3 papers on CoChatORCID 0000-0003-0754-9285
Most cited papers
- Verified
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 4,616
- Verified
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 1,119
- Verified
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Vijiaratnam, N., Girges, C., Auld, G., McComish, R., King, A., Skene, S. S., Hibbert, S., Wong, A., Melander, S., Gibson, R., et al. (2025) · The Lancet
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 181
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free